2015 annual financial data
CRISPR Therapeutics 2015 Operating margin
CRISPR Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was -10,416.6%.
Operating income was -25,729,000 USD and net income was -25,828,000 USD.
Operating cash flow was 59,428,000 USD.
Get free CRISPR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 247,000 USD
- Operating income
- -25,729,000 USD
- Net income
- -25,828,000 USD
- Operating cash flow
- 59,428,000 USD